Name : CREPT Antibody
Supplier : BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price :263
SKU : GEN3670435893
| Long name | CREPT Primary Polyclonal Antibody |
| Also known as | CREPT PAb |
| Category | Primary Antibodies |
| Conjugation | Unconjugated |
| Target Antigen | CREPT |
| Specificity | This is a highly specific antibody against CREPT |
| Modification(s) | None |
| Modification site(s) | Unmodified antibody |
| Clonality | Polyclonal antibody |
| Clone number | Polyclonal antibody |
| Concentration | 1ug per 1ul |
| Source | This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CREPT |
| Tested Applications | IF(IHC-P), IHC-P, WB |
| Recommended dilutions | IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity | Mouse, Rat, Human |
| Cross reactive species details | not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen | Also enhances the transcription of a number ofother cell cycle-related genes including CDK2, CDK4, CDK6 andcyclin-E but not CDKN1A, CDKN1B or cyclin-A, Prevents RNA polymerase II fromreading through the 3' end termination site and may allow it to berecruited back to the promoter through promotion of the formationof a chromatin loop, Promotes cell proliferation, and participates in dephosphorylation of the CTD, Interacts with phosphorylated C-terminal heptapeptiderepeat domain (CTD) of the largest RNA polymerase II subunitPOLR2A, Promotes binding of RNA polymerase II to the CCDN1 promoter and tothe termination region before the poly-A site but decreases itsbinding after the poly-A site, Transcriptional regulator which enhances expression of CCND1 |
| Purification method | This antibody was purified via Protein A |
| Storage conditions | 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names | CREPT, Cell cycle related and expression elevated protein in tumor, Chromosome 20 open reading frame 77, DKFZp434P0735, FLJ44520, Hypothetical protein LOC58490, RPR1B_HUMAN, Uncharacterized protein C20orf77, dJ1057B20, 2, C20orf77 |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target | CREPT |
| Short name | CREPT Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | CREPT (Antibody to) |
| Alternative technique | antibodies |
| Identity | 16209 |
| Gene | RPRD1B |
| Long gene name | regulation of nuclear pre-mRNA domain containing 1B |
| Synonyms gene | C20orf77 |
| Synonyms gene name | chromosome 20 open reading frame 77 |
| Synonyms | dJ1057B20, 2 DKFZp434P0735 CREPT FLJ44520 NET60 |
| Synonyms name | cell-cycle related and expression-elevated protein in tumor |
| Locus | 20q11, 23 |
| Discovery year | 2001-07-17 |
| GenBank acession | AL109823 |
| Entrez gene record | 58490 |
| Pubmed identfication | 22231121 |
| RefSeq identity | NM_021215 |
| Havana BLAST/BLAT | OTTHUMG00000032434 |